Rift Valley Fever Virus

By  

Current Molecular Medicine, Vol. 5, Iss. 8, 2005-01 ,pp. : 827-834

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Hypothesis to Explain the Hemorrhagic and Connective Tissue Manifestations of Ebola Virus Infection

By Tilson M.D.   Ozsvath K.J.   Hirose H.   Xia S.   Lahita R.  

Clinical Immunology, Vol. 81, Iss. 3, 1996-12 ,pp. : 303-306

Academic Press

Access to resources Recommend Favorite

Do therapeutic antibodies hold the key to an effective treatment for Ebola hemorrhagic fever?

By Takada Ayato  

Immunotherapy, Vol. 5, Iss. 5, 2013-05 ,pp. : 441-443

Future Medicine

Access to resources Recommend Favorite

Yellow fever vector live-virus vaccines: West Nile virus vaccine development

By Arroyo J.   Miller C.A.   Catalan J.   Monath T.P.  

Trends in Molecular Medicine, Vol. 7, Iss. 8, 2001-08 ,pp. : 350-354

Elsevier

Access to resources Recommend Favorite

Systemic and ocular antibody responses to inactivated acute hemorrhagic conjunctivitis (AHC) virus; enterovirus 70 (EV70)

By Langford Marlyn P.   Orillac Rogelio   Chen Dequan   Texada Donald E.  

Ocular Immunology and Inflammation, Vol. 11, Iss. 3, 2003-09 ,pp. : 197-209

Informa Healthcare

Access to resources Recommend Favorite